Lexicon Pharmaceuticals, Inc. (LXRX): Insiders Aren’t Crazy About It

In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.

Keep Reading →